Enuresis, sleep and desmopressin treatment
- PMID: 12434900
- DOI: 10.1080/080352502760311647
Enuresis, sleep and desmopressin treatment
Abstract
Aim: To detect effects of desmopressin on sleep in enuretic children and to look for polysomnographical differences between responders and non-responders to desmopressin treatment.
Methods: Twenty-one children with primary nocturnal enuresis were examined polysomnographically before treatment. All but one of the children then received treatment with desmopressin in standard dosage, and the response was documented. Seven of the children underwent a second polysomnographic registration while on treatment.
Results: The time interval (+/- 1 SD) between sleep onset and the enuretic episode was 92 +/- 67 min without medication and 372 +/- 157 min when desmopressin was given (p = 0.003). Standard polysomnographic variables were not affected by the drug. Ten children were desmopressin responders and 10 were non-responders. The total sleep time was 455 +/- 56 min in the former and 408 +/- 31 min in the latter group (p = 0.04). The responders spent 27.4 +/- 5.5% of their total sleep time in rapid eye movement sleep, compared with 18.2 +/- 6.5% in the non-responder group (p = 0.004).
Conclusion: Desmopressin has no major effects on sleep as such but does delay bladder emptying. Enuretic children responding to desmopressin treatment have more rapid eye movement sleep than therapy-resistant children.
Similar articles
-
Sleep of children with enuresis: a polysomnographic study.Pediatrics. 1999 Jun;103(6 Pt 1):1193-7. doi: 10.1542/peds.103.6.1193. Pediatrics. 1999. PMID: 10353928
-
The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis.J Urol. 1996 Aug;156(2 Pt 2):651-5. doi: 10.1097/00005392-199608001-00022. J Urol. 1996. PMID: 8683752 Clinical Trial.
-
Desmopressin resistant enuresis: pathogenetic and therapeutic considerations.J Urol. 1999 Dec;162(6):2136-40. doi: 10.1016/S0022-5347(05)68142-6. J Urol. 1999. PMID: 10569604 Clinical Trial.
-
Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents.BJU Int. 2002 Mar;89(4):420-5. doi: 10.1046/j.1464-4096.2001.01546.x. BJU Int. 2002. PMID: 11872036 Review. No abstract available.
-
Desmopressin treatment: current status.Scand J Urol Nephrol Suppl. 1999;202:70-2. doi: 10.1080/00365599950510274. Scand J Urol Nephrol Suppl. 1999. PMID: 10573800 Review.
Cited by
-
Pitfalls in studies of children with monosymptomatic nocturnal enuresis.Pediatr Nephrol. 2008 Feb;23(2):173-8. doi: 10.1007/s00467-007-0688-7. Epub 2007 Dec 4. Pediatr Nephrol. 2008. PMID: 18057964
-
Enuresis nocturna and sleep quality.Pediatr Nephrol. 2008 Aug;23(8):1293-6. doi: 10.1007/s00467-008-0817-y. Epub 2008 May 28. Pediatr Nephrol. 2008. PMID: 18506489 Clinical Trial.
-
The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis.Int Urol Nephrol. 2008;40(3):583-6. doi: 10.1007/s11255-008-9355-6. Epub 2008 Mar 5. Int Urol Nephrol. 2008. PMID: 18320340 Clinical Trial.
-
Exploring clinical and urinary factors in treatment-resistant vs. treatment-responsive childhood enuresis: a comparative study.BMC Pediatr. 2025 Apr 23;25(1):321. doi: 10.1186/s12887-025-05669-7. BMC Pediatr. 2025. PMID: 40269801 Free PMC article.
-
[Primary monosymptomatic enuresis: diagnostics and therapy].Urologe A. 2013 Jan;52(1):9-10, 12-4. doi: 10.1007/s00120-012-3074-4. Urologe A. 2013. PMID: 23292255 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical